PL2943227T3 - Triazynowe radiofarmaceutyki i środki do obrazowania radiologicznego - Google Patents
Triazynowe radiofarmaceutyki i środki do obrazowania radiologicznegoInfo
- Publication number
- PL2943227T3 PL2943227T3 PL14738117T PL14738117T PL2943227T3 PL 2943227 T3 PL2943227 T3 PL 2943227T3 PL 14738117 T PL14738117 T PL 14738117T PL 14738117 T PL14738117 T PL 14738117T PL 2943227 T3 PL2943227 T3 PL 2943227T3
- Authority
- PL
- Poland
- Prior art keywords
- triazine based
- based radiopharmaceuticals
- radioimaging agents
- radioimaging
- agents
- Prior art date
Links
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 239000012217 radiopharmaceutical Substances 0.000 title 1
- 229940121896 radiopharmaceutical Drugs 0.000 title 1
- 230000002799 radiopharmaceutical effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/481—Diagnostic techniques involving the use of contrast agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- High Energy & Nuclear Physics (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361752350P | 2013-01-14 | 2013-01-14 | |
| US201361785788P | 2013-03-14 | 2013-03-14 | |
| PCT/US2014/011047 WO2014110372A1 (en) | 2013-01-14 | 2014-01-10 | Triazine based radiopharmaceuticals and radioimaging agents |
| EP14738117.2A EP2943227B8 (en) | 2013-01-14 | 2014-01-10 | Triazine based radiopharmaceuticals and radioimaging agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2943227T3 true PL2943227T3 (pl) | 2018-02-28 |
Family
ID=51167394
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17187271T PL3300746T3 (pl) | 2013-01-14 | 2014-01-10 | Oparte na triazynie radiofarmaceutyki i środki radioobrazujące |
| PL14738117T PL2943227T3 (pl) | 2013-01-14 | 2014-01-10 | Triazynowe radiofarmaceutyki i środki do obrazowania radiologicznego |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17187271T PL3300746T3 (pl) | 2013-01-14 | 2014-01-10 | Oparte na triazynie radiofarmaceutyki i środki radioobrazujące |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US9447121B2 (pl) |
| EP (4) | EP3300746B1 (pl) |
| JP (2) | JP6468602B2 (pl) |
| KR (1) | KR102187940B1 (pl) |
| CN (1) | CN105025933B (pl) |
| AU (1) | AU2014205304B2 (pl) |
| BR (1) | BR112015016585B1 (pl) |
| CA (1) | CA2897437C (pl) |
| ES (2) | ES2648096T3 (pl) |
| HU (2) | HUE044552T2 (pl) |
| MX (1) | MX378439B (pl) |
| PL (2) | PL3300746T3 (pl) |
| SG (1) | SG11201505477TA (pl) |
| WO (1) | WO2014110372A1 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2897437C (en) * | 2013-01-14 | 2021-12-14 | Molecular Insight Pharmaceuticals, Inc. | Triazine based radiopharmaceuticals and radioimaging agents |
| GEP20237497B (en) | 2013-10-18 | 2023-04-10 | Deutsches Krebsforsch | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| JP6749249B2 (ja) * | 2014-05-06 | 2020-09-02 | ザ ジョンズ ホプキンズ ユニヴァーシティー | Ｐｓｍａを標的としたイメージング及び放射線治療のための金属／放射性金属標識ｐｓｍａ阻害剤 |
| US9956305B2 (en) | 2014-09-08 | 2018-05-01 | Molecular Insight Pharmaceuticals, Inc. | Organ protection in PSMA-targeted radionuclide therapy of prostate cancer |
| EP3101012A1 (en) | 2015-06-04 | 2016-12-07 | Bayer Pharma Aktiengesellschaft | New gadolinium chelate compounds for use in magnetic resonance imaging |
| US10688200B2 (en) * | 2015-12-31 | 2020-06-23 | Five Eleven Pharma Inc. | Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy |
| PT3925952T (pt) | 2016-03-22 | 2023-12-13 | Univ Johns Hopkins | Agentes alvo de alta afinidade direcionados ao antigénio de membrana específica da próstata para endo radioterapia de cancro da próstata |
| ES3041039T3 (en) * | 2016-10-27 | 2025-11-06 | Progenics Pharm Inc | Network for medical image analysis, decision support system, and related graphical user interface (gui) applications |
| ES2814555T3 (es) | 2016-11-28 | 2021-03-29 | Bayer Pharma AG | Compuestos de quelato de gadolinio con alta relaxividad para usar en la obtención de imágenes por resonancia magnética |
| US11478558B2 (en) | 2017-05-30 | 2022-10-25 | The Johns Hopkins University | Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer |
| ES2912392T3 (es) | 2017-06-19 | 2022-05-25 | Futurechem Co Ltd | Compuesto marcado con 18F para el diagnóstico del cáncer de próstata y uso del mismo |
| WO2018236115A1 (ko) * | 2017-06-19 | 2018-12-27 | (주)퓨쳐켐 | 전립선암 진단을 위한 18f-표지된 화합물 및 그의 용도 |
| EA202092333A1 (ru) | 2018-03-30 | 2021-01-21 | Фьючеркем Ко., Лтд. | Псма-таргетные радиофармацевтические средства для диагностики и лечения рака простаты |
| EP3883613A1 (en) | 2018-11-23 | 2021-09-29 | Bayer Aktiengesellschaft | Formulation of contrast media and process of preparation thereof |
| JP7729609B2 (ja) * | 2019-04-26 | 2025-08-26 | ファイブ イレブン ファーマ インコーポレイテッド | 診断および放射性核種治療剤としての前立腺特異的膜抗原（ｐｓｍａ）阻害剤 |
| WO2023092184A1 (en) * | 2021-11-24 | 2023-06-01 | Clarity Pharmaceuticals Ltd | Compounds and compositions thereof for the treatment of cancer |
| CN116199736B (zh) * | 2023-03-01 | 2025-03-18 | 西南医科大学附属医院 | 一种DOTA-Te-PSMA化合物及其应用 |
Family Cites Families (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2800457A (en) | 1953-06-30 | 1957-07-23 | Ncr Co | Oil-containing microscopic capsules and method of making them |
| US2730456A (en) | 1953-06-30 | 1956-01-10 | Ncr Co | Manifold record material |
| US2730457A (en) | 1953-06-30 | 1956-01-10 | Ncr Co | Pressure responsive record materials |
| US3527789A (en) | 1967-10-06 | 1970-09-08 | Shell Oil Co | Production of poly(lower)alkyl alkenepolycarboxylates |
| US3625214A (en) | 1970-05-18 | 1971-12-07 | Alza Corp | Drug-delivery device |
| JPS5220203B2 (pl) | 1973-03-05 | 1977-06-02 | ||
| US4272398A (en) | 1978-08-17 | 1981-06-09 | The United States Of America As Represented By The Secretary Of Agriculture | Microencapsulation process |
| US4906474A (en) | 1983-03-22 | 1990-03-06 | Massachusetts Institute Of Technology | Bioerodible polyanhydrides for controlled drug delivery |
| JPS6131056A (ja) | 1984-07-25 | 1986-02-13 | K Baiorojikaru Sci Lab:Kk | ホイッピングクリームの製造方法 |
| US4885363A (en) | 1987-04-24 | 1989-12-05 | E. R. Squibb & Sons, Inc. | 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
| JP2876058B2 (ja) | 1986-08-18 | 1999-03-31 | エミスフィア・テクノロジーズ・インコーポレイテッド | 薬物送達システム |
| JP2608550B2 (ja) | 1986-10-17 | 1997-05-07 | 株式会社 片山化学工業研究所 | 軟水ボイラの防食処理方法 |
| US4888136A (en) | 1988-05-02 | 1989-12-19 | Witco Corporation | New flame retardant compositions of matter and cellulosic products containing same |
| TW353663B (en) | 1991-04-06 | 1999-03-01 | Hoechst Ag | Process for the preparation of phosphorus-containing L-amino acids, their derivatives and intermediates for this process |
| JP3051497B2 (ja) | 1991-05-17 | 2000-06-12 | 株式会社第一ラジオアイソトープ研究所 | スルファニルアミド誘導体のテクネチウム錯体をもちいる放射性診断剤 |
| US6359120B1 (en) | 1991-10-29 | 2002-03-19 | Bracco International B.V. | Rhenium and technetium complexes containing a hypoxia-localizing moiety |
| IL103353A (en) | 1991-10-29 | 1999-01-26 | Bracco Int Bv | Ligand metal complexes thereof diagnostic composition and processes for their preparation |
| IT1270260B (it) | 1994-06-21 | 1997-04-29 | Zambon Spa | Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi |
| US6011021A (en) | 1996-06-17 | 2000-01-04 | Guilford Pharmaceuticals Inc. | Methods of cancer treatment using naaladase inhibitors |
| JP2856098B2 (ja) | 1995-04-11 | 1999-02-10 | 日本製紙株式会社 | 感熱記録シート |
| US5514505A (en) * | 1995-05-15 | 1996-05-07 | Xerox Corporation | Method for obtaining improved image contrast in migration imaging members |
| US5795877A (en) | 1996-12-31 | 1998-08-18 | Guilford Pharmaceuticals Inc. | Inhibitors of NAALADase enzyme activity |
| US6025344A (en) | 1996-06-17 | 2000-02-15 | Guilford Pharmaceuticals Inc. | Certain dioic acid derivatives useful as NAALADase inhibitors |
| US5824662A (en) | 1996-09-27 | 1998-10-20 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
| US6046180A (en) | 1996-06-17 | 2000-04-04 | Guilford Pharmaceuticals Inc. | NAALADase inhibitors |
| US5672592A (en) | 1996-06-17 | 1997-09-30 | Guilford Pharmaceuticals Inc. | Certain phosphonomethyl-pentanedioic acid derivatives thereof |
| US5902817A (en) | 1997-04-09 | 1999-05-11 | Guilford Pharmaceuticals Inc. | Certain sulfoxide and sulfone derivatives |
| US6071965A (en) | 1996-06-17 | 2000-06-06 | Guilford Pharmaceuticals Inc. | Phosphinic alkanoic acid derivatives |
| CN1230889A (zh) | 1996-09-27 | 1999-10-06 | 吉尔福特药业有限公司 | NAALADase组合物和治疗谷氨酸异常及在动物中产生神经元活性的方法 |
| US5962521A (en) | 1997-04-04 | 1999-10-05 | Guilford Pharmaceuticals Inc. | Hydroxamic acid derivatives |
| ZA983930B (en) | 1997-05-14 | 1999-11-08 | Lilly Co Eli | Excitatory amino acid receptor modulators. |
| DK1064273T3 (da) | 1998-03-19 | 2003-03-31 | Upjohn Co | 1,3,4-Thiadiazoler, som er nyttige til behandling af CMV-infektioner |
| DE60020962T2 (de) | 1999-04-28 | 2006-05-24 | Georgetown University | Liganden für metabotropische Glutamat-Rezeptoren |
| US6528499B1 (en) | 2000-04-27 | 2003-03-04 | Georgetown University | Ligands for metabotropic glutamate receptors and inhibitors of NAALADase |
| US6228888B1 (en) | 1999-07-01 | 2001-05-08 | Guilford Pharmaceuticals Inc. | Methods for treating anxiety, anxiety disorders and memory impairment using naaladase inhibitors |
| US20040157818A1 (en) | 2001-05-24 | 2004-08-12 | Mikiro Yanaka | Cxcr4-antagonistic drugs composed of nitrogen-containing compound |
| DE10135355C1 (de) | 2001-07-20 | 2003-04-17 | Schering Ag | Konjugate makrocyclischer Metallkomplexe mit Biomolekülen und deren Verwendung zur Herstellung von Mitteln für die NMR- und Radiodiagnostik sowie die Radiotherapie |
| US20030100594A1 (en) | 2001-08-10 | 2003-05-29 | Pharmacia Corporation | Carbonic anhydrase inhibitor |
| WO2003053932A1 (en) | 2001-12-21 | 2003-07-03 | Tohru Koike | Zinc complexes capable of scavenging substances bearing anionic substituents |
| PT1472541E (pt) | 2002-01-10 | 2009-12-21 | Univ Johns Hopkins | Agentes de imagiologia e métodos de imagiologia de naaladase de psma |
| ES2559764T3 (es) | 2002-03-11 | 2016-02-15 | Molecular Insight Pharmaceuticals, Inc. | Complejos de tecnecio-dipiridina, y métodos de uso de los mismos |
| US7176227B2 (en) | 2002-09-11 | 2007-02-13 | Kureha Corporation | Amine compounds and use thereof |
| SI2594265T1 (sl) | 2002-11-26 | 2016-03-31 | Institute Of Virology Slovak Academy Of Sciences | CA-IX specifični inhibitorji |
| US7833734B2 (en) | 2002-11-26 | 2010-11-16 | Institute Of Virology Of The Slovak Academy Of Sciences | CA IX-specific inhibitors |
| US7291631B2 (en) | 2003-04-11 | 2007-11-06 | Genzyme Corporation | CXCR4 chemokine receptor binding compounds |
| US7682601B2 (en) | 2003-04-15 | 2010-03-23 | Mallinckrodt Inc. | Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes |
| WO2005056520A1 (en) | 2003-12-12 | 2005-06-23 | Oy Juvantia Pharma Ltd | Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy |
| CA2555963A1 (en) | 2004-02-12 | 2005-09-01 | Molecular Insight Pharmaceuticals | Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| GB0421308D0 (en) | 2004-09-24 | 2004-10-27 | Amersham Plc | Enzyme inhibitor imaging agents |
| WO2008059489A2 (en) | 2006-11-13 | 2008-05-22 | Spectrum Dynamics Llc | Radioimaging applications of and novel formulations of teboroxime |
| WO2006080993A1 (en) | 2004-12-08 | 2006-08-03 | Purdue Research Foundation | Novel cationic metal complex radiopharmaceuticals |
| US20060155021A1 (en) | 2005-01-13 | 2006-07-13 | Lenges Christian P | Coating compositions containing rheology control agents |
| US7741510B2 (en) | 2005-01-13 | 2010-06-22 | E. I. Du Pont De Nemours And Company | Rheology control agents |
| WO2006093991A1 (en) | 2005-03-02 | 2006-09-08 | The Cleveland Clinic Foundation | Compounds which bind psma and uses thereof |
| ATE527542T1 (de) | 2005-04-27 | 2011-10-15 | Siemens Medical Solutions | Verfahren zur herstellung von abbildungssonden unter verwendung von click chemie |
| US8871720B2 (en) | 2005-07-07 | 2014-10-28 | Seattle Genetics, Inc. | Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus |
| FR2890657B1 (fr) | 2005-09-15 | 2007-11-09 | Commissariat Energie Atomique | Procede d'obtention de complexes de lanthanides hautement luminescents. |
| US8926945B2 (en) | 2005-10-07 | 2015-01-06 | Guerbet | Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium |
| WO2007058322A1 (ja) | 2005-11-18 | 2007-05-24 | Ono Pharmaceutical Co., Ltd. | 塩基性基を含有する化合物およびその用途 |
| US20090044345A1 (en) | 2006-02-06 | 2009-02-19 | Gunther Schlingloff | Use of Metal Complex Compounds as Oxidation Catalysts |
| US8618122B2 (en) | 2006-05-16 | 2013-12-31 | Ono Pharmaceutical Co., Ltd. | Compound having acidic group which may be protected, and use thereof |
| MX2009000144A (es) | 2006-06-20 | 2009-01-23 | Ishihara Sangyo Kaisha | Agente de control de plaga que contiene derivado de piridil-metanamina novedoso o su sal. |
| JP5245827B2 (ja) | 2006-07-31 | 2013-07-24 | 小野薬品工業株式会社 | スピロ結合した環状基を含有する化合物およびその用途 |
| BRPI0716368A2 (pt) | 2006-08-29 | 2013-10-01 | Molecular Insight Pharm Inc | porÇÕes de radioimageamento acopladas a porÇÕes de ligaÇço Á peptidase para imageamento de tecidos e àrgços que expressam peptidases |
| US20080193381A1 (en) * | 2006-11-08 | 2008-08-14 | Molecular Insight Pharmaceuticals, Inc. | Heterodimers of glutamic acid |
| WO2008124703A2 (en) | 2007-04-05 | 2008-10-16 | Siemens Medical Solutions Usa, Inc. | Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry |
| WO2009076434A1 (en) | 2007-12-12 | 2009-06-18 | Molecular Insight Pharmaceuticals, Inc. | Inhibitors of integrin vla-4 |
| BRPI0906797A2 (pt) | 2008-01-09 | 2015-07-14 | Molecular Insight Pharm Inc | Inibidores de anidrase carbônica ix |
| TW201006830A (en) * | 2008-06-11 | 2010-02-16 | Astrazeneca Ab | Chemical compounds |
| JP2012503670A (ja) | 2008-09-25 | 2012-02-09 | モレキュラ インサイト ファーマシューティカルズ インコーポレイテッド | 選択的セプラーゼ阻害剤 |
| US8211402B2 (en) | 2008-12-05 | 2012-07-03 | Molecular Insight Pharmaceuticals, Inc. | CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer |
| EP2706057B1 (en) | 2008-12-05 | 2016-04-20 | Molecular Insight Pharmaceuticals, Inc. | Bis(imidazolyl)compounds and radionuclide complexes |
| EP2373621A2 (en) | 2008-12-05 | 2011-10-12 | Molecular Insight Pharmaceuticals, Inc. | Technetium-and rhenium-bis(heteroaryl)complexes and methods of use thereof |
| ES2712732T3 (es) | 2009-02-17 | 2019-05-14 | Cornell Res Foundation Inc | Métodos y kits para el diagnóstico de cáncer y la predicción de valor terapéutico |
| HRP20221195T1 (hr) * | 2009-03-19 | 2022-12-09 | The Johns Hopkins University | Spojevi koji ciljaju psma i njihova uporaba |
| GB201002508D0 (en) * | 2010-02-12 | 2010-03-31 | Algeta As | Product |
| WO2012074840A2 (en) * | 2010-11-22 | 2012-06-07 | The General Hospital Corporation | Compositions and methods for in vivo imaging |
| EP2648766B1 (en) | 2010-12-06 | 2018-04-18 | Molecular Insight Pharmaceuticals, Inc. | Psma-targeted dendrimers |
| EP3505192A1 (en) | 2011-08-05 | 2019-07-03 | Molecular Insight Pharmaceuticals, Inc. | Radiolabeled prostate specific membrane antigen inhibitors |
| WO2013166110A1 (en) | 2012-05-02 | 2013-11-07 | Yale University | Tlr-agonist-conjugated antibody recruiting molecules (tlr_arms) |
| CA2897437C (en) | 2013-01-14 | 2021-12-14 | Molecular Insight Pharmaceuticals, Inc. | Triazine based radiopharmaceuticals and radioimaging agents |
-
2014
- 2014-01-10 CA CA2897437A patent/CA2897437C/en active Active
- 2014-01-10 US US14/152,864 patent/US9447121B2/en active Active
- 2014-01-10 ES ES14738117.2T patent/ES2648096T3/es active Active
- 2014-01-10 CN CN201480011222.1A patent/CN105025933B/zh active Active
- 2014-01-10 WO PCT/US2014/011047 patent/WO2014110372A1/en not_active Ceased
- 2014-01-10 ES ES17187271T patent/ES2738474T3/es active Active
- 2014-01-10 BR BR112015016585-0A patent/BR112015016585B1/pt active IP Right Grant
- 2014-01-10 KR KR1020157021666A patent/KR102187940B1/ko active Active
- 2014-01-10 EP EP17187271.6A patent/EP3300746B1/en active Active
- 2014-01-10 HU HUE17187271 patent/HUE044552T2/hu unknown
- 2014-01-10 HU HUE14738117A patent/HUE035739T2/en unknown
- 2014-01-10 EP EP19174044.8A patent/EP3545978B1/en active Active
- 2014-01-10 AU AU2014205304A patent/AU2014205304B2/en active Active
- 2014-01-10 PL PL17187271T patent/PL3300746T3/pl unknown
- 2014-01-10 JP JP2015552805A patent/JP6468602B2/ja active Active
- 2014-01-10 PL PL14738117T patent/PL2943227T3/pl unknown
- 2014-01-10 EP EP21190931.2A patent/EP3939972A1/en not_active Withdrawn
- 2014-01-10 SG SG11201505477TA patent/SG11201505477TA/en unknown
- 2014-01-10 MX MX2015008993A patent/MX378439B/es unknown
- 2014-01-10 EP EP14738117.2A patent/EP2943227B8/en active Active
-
2016
- 2016-08-10 US US15/233,096 patent/US10201624B2/en active Active
-
2017
- 2017-04-20 US US15/492,933 patent/US10086096B2/en active Active
-
2018
- 2018-12-21 US US16/231,153 patent/US10898598B2/en active Active
-
2019
- 2019-01-10 JP JP2019002515A patent/JP6707677B2/ja active Active
-
2020
- 2020-12-21 US US17/129,825 patent/US11712485B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201505477TA (en) | Triazine based radiopharmaceuticals and radioimaging agents | |
| IL274355B (en) | Aza-pyridone compounds and their uses | |
| GB201323008D0 (en) | Compounds and uses thereof | |
| IL244434B (en) | Pyridazinone compounds and their uses | |
| GB201305277D0 (en) | Novel combination and use | |
| HUE044890T2 (hu) | Tetrazolinon vegyület és annak felhasználása | |
| GB2513227B (en) | Backpack | |
| IL243361B (en) | Radioactively labeled material | |
| GB201322456D0 (en) | Radiotracer compositions and methods | |
| GB201321056D0 (en) | Debug circuitry | |
| GB201307233D0 (en) | Compounds and uses thereof | |
| GB201311107D0 (en) | Bioorthogonal methods and compounds | |
| EP2974713A4 (en) | CERAMIDES FOR FUNCTIONAL ACTIVATION | |
| ZA201602676B (en) | Parent radionuclide container | |
| LT2958454T (lt) | Magnetoterapijos juosta | |
| GB201314936D0 (en) | Radiolabelling method | |
| GB201309180D0 (en) | Compounds and Their Uses | |
| GB201314610D0 (en) | Compounds and their uses | |
| GB201306248D0 (en) | Compounds and their uses | |
| GB201305297D0 (en) | Novel agents and uses thereof | |
| GB201309248D0 (en) | Compounds and combinations | |
| AU353456S (en) | Hammock | |
| PH32013001091S1 (en) | Toothbrush and portions thereof | |
| PH32013001020S1 (en) | Toothbrush and portions thereof | |
| GB201313405D0 (en) | Hammock |